Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes
Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes
This trial is conducted in South Africa. The aim of this trial is to investigate Long term
 safety of biphasic insulin aspart 30 in juveniles with type 1 diabetes previously treated in
 trial BIAsp-1240.
Inclusion Criteria:

 -  Signed informed consent obtained before any trial-related activities according to
 local requirements. (Trial-related activities are any procedure that would not have
 been performed during normal management of the subject)

 -  The subject must have completed the trial BIAsp-1240